Lebovits Chaim Insider Trades

Insider Trading History

Track insider trading activity for Lebovits Chaim. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $170k 200,960 shares
Last Trade
Jan 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 120,000 shares
$2.27
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $68.6k 80,960 shares
Last Trade
Oct 01, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.3k 1,836 shares
$3.43
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $1.01M 1,186,865 shares
Last Trade
Sep 30, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$75.9k 22,000 shares
$3.45
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $987k 1,164,865 shares
Last Trade
May 28, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$116k 15,000 shares
$7.75
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $987k 1,164,865 shares
Last Trade
May 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116k 15,000 shares
$7.75
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $974k 1,149,865 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$215k 25,000 shares
$8.58
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $974k 1,149,865 shares
Last Trade
May 22, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$215k 25,000 shares
$8.58
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $953k 1,124,865 shares
Last Trade
May 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 25,000 shares
$9.30
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $953k 1,124,865 shares
Last Trade
May 21, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$233k 25,000 shares
$9.30
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $931k 1,099,865 shares
Last Trade
May 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.2k 10,000 shares
$8.22
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $931k 1,099,865 shares
Last Trade
May 13, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$82.2k 10,000 shares
$8.22
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $923k 1,089,865 shares
Last Trade
May 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.4k 10,000 shares
$6.84
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $923k 1,089,865 shares
Last Trade
May 11, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$68.4k 10,000 shares
$6.84
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $915k 1,079,865 shares
Last Trade
May 10, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$137k 20,000 shares
$6.84
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $915k 1,079,865 shares
Last Trade
May 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$137k 20,000 shares
$6.84
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $898k 1,059,865 shares
Last Trade
May 07, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$366k 66,300 shares
$5.52
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $898k 1,059,865 shares
Last Trade
May 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$366k 66,300 shares
$5.52
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $841k 993,565 shares
Last Trade
May 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$757k 135,000 shares
$5.61
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $841k 993,565 shares
Last Trade
May 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$757k 135,000 shares
$5.61
$0.85
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
President & CEO
Holding Value $727k 858,565 shares
Last Trade
Apr 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 15,000 shares
$7.98
$0.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up